A new study from Louisiana State University demonstrates that chromium improves blood sugar control and insulin sensitivity among diabetics. In the 10-month study, those who received 500 mcg of chromium picolinate twice a day experienced significantly improved insulin sensitivity, had less weight gain, less abdominal fat and lower glyco-hemoglobin (an indication of sugar-induced damage to tissues).
Reductions in blood sugar, weight and cholesterol levels leave little doubt that chromium may be a wise choice for diabetics.
University of Vermont researchers report similar findings. In their study involving 37 people with type 2 diabetes, individuals who received 1,000 mcg of chromium picolinate daily for six months, along with diabetes medication, showed improved insulin sensitivity and glucose control compared to a placebo group. Those who received supplements also experienced reduced weight gain and fat accumulation.
A third study, this one from Israel, points to chromium supplementation as beneficial for older people with type 2 diabetes. Along with standard treatment for the disease, 39 people with diabetes received 200 mcg of chromium picolinate twice daily for three weeks. Meanwhile, 39 others received a placebo. The average age of study participants was 73 and all were undergoing rehabilitation following strokes or hip fractures.
The researchers concluded that among elderly diabetic patients undergoing rehabilitation, "dietary supplementation with chromium is beneficial in moderating glucose intolerance. In addition, chromium intake appears to lower plasma lipid levels."
Sources: Diabetes Care. 2006 Aug;29(8):1826-32; Int J Vitam Nutr Res. 2004 May;74(3):178-82
